← Open Payments lookup

SHELLEY GUARNERA: Open Payments

NPI 1174254411 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$733 in 32 payments from 12 companies in 2025. Trend: 2023 $499 · 2024 $182 · 2025 $733

Food & beverage: $733
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$214
Indivior Inc.3$87
Alkermes, Inc.3$74
E.R. Squibb & Sons, L.L.C.3$74
ABBVIE INC.4$62
Teva Pharmaceuticals USA, Inc.2$54
Takeda Pharmaceuticals U.S.A., Inc.2$49
Lundbeck LLC2$38
Janssen Pharmaceuticals, Inc1$28
Neurocrine BioSciences, Inc.1$21

Products named: REXULTI, SUBLOCADE, ARISTADA, COBENFY, VRAYLAR, AUSTEDO XR, TRINTELLIX, SPRAVATO.

Industry payments across NV — which companies pay providers there.